INTELLIONS

Serial Number 86551687
606

Registration Progress

Application Filed
Mar 3, 2015
Under Examination
Aug 25, 2015
Approved for Publication
Jun 30, 2015
Published for Opposition
Jun 30, 2015
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: INTELLIONS
Previous Owner: Intellia Therapeutics, Inc.
Classes: 005

Trademark Image

INTELLIONS

Basic Information

Serial Number
86551687
Filing Date
March 3, 2015
Published for Opposition
June 30, 2015
Abandonment Date
March 28, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 28, 2016
Classes
005

Rights Holder

Intellia Therapeutics, Inc.

03
Address
Suite 303
25 First Street
Cambridge, MA 02141

Ownership History

Intellia Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Intellia Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Lawrence R. Robins

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

12 events
Date Code Type Description Documents
Mar 28, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 28, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 25, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 30, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 30, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 10, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 22, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 18, 2015 ALIE A ASSIGNED TO LIE Loading...
Apr 23, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 23, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 16, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 6, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Viral-based vectors used to insert and deliver gene editing and repairing therapeutic products into human and animal genes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005